 | Up a level |
Achard, V.; Putora, P. M.; Omlin, A.; Zilli, T.; Fischer, S. (2022). Metastatic Prostate Cancer: Treatment Options. Oncology, 100(1), pp. 48-59. Karger 10.1159/000519861
Glatzer, Markus; Horber, D.; Montemurro, M.; Winterhalder, R.; Inauen, R.; Berger, M. D.; Pestalozzi, B.; Pederiva, S.; Pless, M.; Putora, P. M. (2020). Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology, 20(4), pp. 686-690. Elsevier 10.1016/j.pan.2020.03.012
De Bruycker, A; Spiessens, A; Dirix, P; Koutsouvelis, N; Semac, I; Liefhooghe, N; Gomez-Iturriaga, A; Everaerts, W; Otte, F; Papachristofilou, A; Scorsetti, M; Shelan, M.; Siva, S; Ameye, F; Guckenberger, M; Heikkilä, R; Putora, P. M.; Zapatero, A; Conde-Moreno, A; Couñago, F; ... (2020). PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC cancer, 20(1), p. 406. BioMed Central 10.1186/s12885-020-06911-4
Hundsberger, T.; Hottinger, A. F.; Roelcke, U.; Roth, P.; Migliorini, D.; Dietrich, P. Y.; Conen, K.; Pesce, G.; Herrmann, Evelyn; Pica, Alessia; Gross, M. W.; Brügge, D.; Plasswilm, Ludwig; Weller, M.; Putora, P. M. (2016). Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. Journal of neuro-oncology, 126(1), pp. 175-183. Springer 10.1007/s11060-015-1957-0
